Researchers used data from a long-term ongoing prospective cohort study in the Netherlands to compare the characteristics of long-COVID in inflammatory rheumatic diseases patients and healthy controls during the period when the SARS-CoV-2 Omicron subvariants, BA.1/BA.2 were dominant.
Study compares long-term consequences of COVID-19 between patients with rheumatic inflammatory diseases and healthy controls
- Thread starter Educator
- Start date